Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

SELL
$161.01 - $317.85 $4.34 Million - $8.56 Million
-26,930 Reduced 13.09%
178,849 $56.6 Million
Q3 2023

Nov 13, 2023

SELL
$164.66 - $218.08 $112,133 - $148,512
-681 Reduced 0.33%
205,779 $34.8 Million
Q2 2023

Aug 09, 2023

BUY
$176.32 - $240.22 $21.4 Million - $29.2 Million
121,630 Added 143.38%
206,460 $44.8 Million
Q1 2023

May 08, 2023

SELL
$161.33 - $204.36 $5.02 Million - $6.36 Million
-31,109 Reduced 26.83%
84,830 $15.4 Million
Q4 2022

Feb 14, 2023

SELL
$191.53 - $236.82 $836,986 - $1.03 Million
-4,370 Reduced 3.63%
115,939 $22.8 Million
Q3 2022

Nov 07, 2022

SELL
$123.79 - $277.42 $635,414 - $1.42 Million
-5,133 Reduced 4.09%
120,309 $27.1 Million
Q2 2022

Aug 10, 2022

SELL
$93.97 - $143.33 $9.85 Million - $15 Million
-104,831 Reduced 45.52%
125,442 $15.9 Million
Q1 2022

May 12, 2022

SELL
$98.9 - $132.37 $1.24 Million - $1.65 Million
-12,497 Reduced 5.15%
230,273 $29.2 Million
Q4 2021

Feb 11, 2022

SELL
$110.64 - $159.4 $1.27 Million - $1.83 Million
-11,450 Reduced 4.5%
242,770 $31.6 Million
Q3 2021

Nov 10, 2021

SELL
$101.2 - $125.87 $2.18 Million - $2.71 Million
-21,506 Reduced 7.8%
254,220 $31.1 Million
Q2 2021

Aug 11, 2021

SELL
$107.45 - $135.95 $1.08 Million - $1.37 Million
-10,041 Reduced 3.51%
275,726 $31.4 Million
Q1 2021

May 14, 2021

BUY
$95.46 - $133.08 $1.75 Million - $2.44 Million
18,360 Added 6.87%
285,767 $35.1 Million
Q4 2020

Feb 12, 2021

SELL
$75.23 - $109.23 $2 Million - $2.91 Million
-26,651 Reduced 9.06%
267,407 $27.2 Million
Q3 2020

Nov 12, 2020

BUY
$71.31 - $109.74 $428,430 - $659,317
6,008 Added 2.09%
294,058 $23.2 Million
Q2 2020

Aug 12, 2020

BUY
$62.14 - $117.21 $11.1 Million - $20.9 Million
178,223 Added 162.28%
288,050 $30.6 Million
Q1 2020

May 11, 2020

BUY
$60.41 - $115.92 $869,299 - $1.67 Million
14,390 Added 15.08%
109,827 $7.91 Million
Q4 2019

Feb 07, 2020

BUY
$11.44 - $123.99 $1.09 Million - $11.8 Million
95,437 New
95,437 $7.19 Million

Others Institutions Holding KRTX

About Karuna Therapeutics, Inc.


  • Ticker KRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 33,965,000
  • Description
  • Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...
More about KRTX
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.